Psychedelics XTL Biopharma to enter psychedelics sector with Psyga Bio takeover The move was significantly inspired by Trump's recent executive order Rowan DunneMay 4, 2026
Psychedelics Compass Pathways scores FDA priority voucher for synthetic psilocybin drug Three companies were awarded the vouchers after Trump's executive order was signed Rowan DunneApril 30, 2026
Psychedelics Optimi Health launches ibogaine initiative in response to Trump’s executive order Psychedelic stocks surged after the president gave his signature Rowan DunneApril 21, 2026